Peripheral, measures of arginine vasopressin, atrial natriuretic peptide and adrenocorticotropic hormone in premenstrual syndrome

被引:11
|
作者
Rosenstein, DL
Kalogeras, KT
Kalafut, M
Malley, J
Rubinow, DR
机构
[1] NIMH, CLIN NEUROENDOCRINOL BRANCH, BETHESDA, MD 20892 USA
[2] UNIV CALIF LOS ANGELES, SCH MED, DEPT NEUROL, LOS ANGELES, CA 90024 USA
[3] NIH, PERSONAL COMP BRANCH, DIV COMP RES & TECHNOL, BETHESDA, MD 20892 USA
关键词
AVP; ANP; ACTH; PMS; menstrual; mood;
D O I
10.1016/0306-4530(95)00035-6
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Because of the unique combination of physical (e.g. bloating, water retention) and psychological (e.g. mood, memory) symptoms associated with premenstrual syndrome (PMS), various hypothalamic and pituitary hormones have been implicated in the pathophysiology of PMS. We measured plasma adrenocorticotropic hormone (ACTH), arginine vasopressin (AW) and atrial natriuretic peptide (ANP) across the menstrual cycle in 19 women with PMS and 12 normal women. AVP concentrations were lower throughout the menstrual cycle in symptomatic PMS patients compared with PMS patients during asymptomatic cycles and normal women. No differences in ACTH and ANP were observed between patients and controls. However, ACTH and ANP were positively and significantly correlated with each other in women with PMS but not in controls. These findings contribute to a growing list of menstrual cycle-independent findings in women with PMS and suggest that there may be an underlying neurobiological vulnerability that predisposes some women to experience somatic and mood dysregulation in the luteal phase of the menstrual cycle. Copyright (C) 1996 Elsevier Science Ltd.
引用
收藏
页码:347 / 359
页数:13
相关论文
共 50 条
  • [1] Effect of progesterone therapy on arginine vasopressin and atrial natriuretic factor in premenstrual syndrome
    Watanabe, H
    Lau, DCW
    Guyn, HL
    Wong, NLM
    CLINICAL AND INVESTIGATIVE MEDICINE-MEDECINE CLINIQUE ET EXPERIMENTALE, 1997, 20 (04): : 211 - 223
  • [2] ARGININE VASOPRESSIN POTENTIATES NATRIURETIC EFFECT OF ATRIAL PEPTIDE
    GRACZAK, LM
    NICOLODI, LK
    HARTUPEE, DA
    BLAINE, EH
    AMERICAN JOURNAL OF PHYSIOLOGY, 1989, 256 (03): : H925 - H927
  • [3] EFFECT OF ARGININE VASOPRESSIN ON FETAL ATRIAL-NATRIURETIC-PEPTIDE SECRETION
    ERVIN, MG
    ROSS, MG
    CALVARIO, GC
    LAM, RW
    LEAKE, RD
    FISHER, DA
    CLINICAL RESEARCH, 1987, 35 (01): : A233 - A233
  • [4] REDUCED ATRIAL-NATRIURETIC-PEPTIDE CONCENTRATIONS IN PREMENSTRUAL-SYNDROME
    HUSSAIN, SY
    OBRIEN, PMS
    DESOUZA, V
    OKONOFUA, F
    DANDONA, P
    BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 1990, 97 (05): : 397 - 401
  • [5] ATRIAL NATRIURETIC PEPTIDE AND ARGININE VASOPRESSIN IN PREGNANCY AND PREGNANCY-INDUCED HYPERTENSION
    ELIAS, AN
    VAZIRI, ND
    PANDIAN, MR
    POWERS, DR
    DOMURAT, E
    NEPHRON, 1988, 49 (02): : 140 - 143
  • [6] EFFECT OF ATRIAL-NATRIURETIC-PEPTIDE ON THIRST AND ARGININE VASOPRESSIN RELEASE IN HUMANS
    BURRELL, LM
    LAMBERT, HJ
    BAYLIS, PH
    AMERICAN JOURNAL OF PHYSIOLOGY, 1991, 260 (03): : R475 - R479
  • [7] RAPID, SIMPLIFIED RADIOIMMUNOASSAY OF ARGININE-VASOPRESSIN AND ATRIAL NATRIURETIC PEPTIDE IN PLASMA
    BODOLA, F
    BENEDICT, CR
    CLINICAL CHEMISTRY, 1988, 34 (05) : 970 - 973
  • [8] EVIDENCE FOR RECEPTORS FOR ARGININE VASOPRESSIN, ATRIAL-NATRIURETIC-PEPTIDE AND BRADYKININ ON CULTURED ASTROCYTES
    ELISABETH, H
    LEFKOVITS, M
    KASER, H
    HOSLI, L
    EUROPEAN JOURNAL OF NEUROSCIENCE, 1992, : 32 - 32
  • [9] Regulation of water channel activity of aquaporin 1 by arginine vasopressin and atrial natriuretic peptide
    Patil, RV
    Han, ZQ
    Wax, MB
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1997, 238 (02) : 392 - 396
  • [10] ATRIAL NATRIURETIC PEPTIDE INHIBITS OSMOLALITY-INDUCED ARGININE VASOPRESSIN RELEASE IN MAN
    ALLEN, MJ
    ANG, VTY
    BENNETT, ED
    JENKINS, JS
    CLINICAL SCIENCE, 1988, 75 (01) : 35 - 39